author_facet Wang, C.
Ahlström, H.
Ekholm, S.
Fagertun, H.
Hellström, M.
Hemmingsson, A.
Holtås, S.
Isberg, B.
Jonnson, E.
Lönnemark-Magnusson, M.
McGill, S.
Wallengren, N.-O.
Westman, L.
Wang, C.
Ahlström, H.
Ekholm, S.
Fagertun, H.
Hellström, M.
Hemmingsson, A.
Holtås, S.
Isberg, B.
Jonnson, E.
Lönnemark-Magnusson, M.
McGill, S.
Wallengren, N.-O.
Westman, L.
author Wang, C.
Ahlström, H.
Ekholm, S.
Fagertun, H.
Hellström, M.
Hemmingsson, A.
Holtås, S.
Isberg, B.
Jonnson, E.
Lönnemark-Magnusson, M.
McGill, S.
Wallengren, N.-O.
Westman, L.
spellingShingle Wang, C.
Ahlström, H.
Ekholm, S.
Fagertun, H.
Hellström, M.
Hemmingsson, A.
Holtås, S.
Isberg, B.
Jonnson, E.
Lönnemark-Magnusson, M.
McGill, S.
Wallengren, N.-O.
Westman, L.
Acta Radiologica
Diagnostic efficacy of MnDPDP in MR imaging of the liver : A phase III multicentre study
Radiology, Nuclear Medicine and imaging
General Medicine
Radiological and Ultrasound Technology
author_sort wang, c.
spelling Wang, C. Ahlström, H. Ekholm, S. Fagertun, H. Hellström, M. Hemmingsson, A. Holtås, S. Isberg, B. Jonnson, E. Lönnemark-Magnusson, M. McGill, S. Wallengren, N.-O. Westman, L. 0284-1851 1600-0455 SAGE Publications Radiology, Nuclear Medicine and imaging General Medicine Radiological and Ultrasound Technology http://dx.doi.org/10.1080/02841859709172395 <jats:p> Purpose: To assess the diagnostic efficacy, safety and tolerability of mangafodipir trisodium (MnDPDP, Teslascan) in MR imaging of the liver. </jats:p><jats:p> Material and Methods: Eighty-two patients from 4 centres underwent MR imaging with pre-contrast sequences including T1-weighted SE and GRE, and T2-weighted turbo SE sequences. MnDPDP at a dose of 5 μmol/kg b.w. was administered by slow i.v. infusion, and 20–60 min after infusion the T1-weighted SE and GRE sequences were repeated. Diagnostic efficacy was evaluated by counting the number of lesions and by evaluating whether more information for lesion characterisation was available in post-contrast images. Safety and tolerability were assessed by recording adverse events and infusion-related discomfort. </jats:p><jats:p> Results: Significantly more lesions were found in MnDPDP-enhanced T1-weighted SE and GRE images than in unenhanced images of the same sequences. More lesions were also found in these images compared with T2-weighted images at a level of marginal significance. More information was obtained from MnDPDP-enhanced images in 40 cases. Mild to moderate adverse events were experienced by 17% of the patients. </jats:p><jats:p> Conclusion: MnDPDP-enhanced images can improve lesion detection in the liver and are helpful for lesion characterisation. To obtain optimal diagnostic information of liver lesions T2-weighted images are also valuable. MnDPDP is a safe contrast agent for MR imaging of liver lesions. </jats:p> A phase III multicentre study Diagnostic efficacy of MnDPDP in MR imaging of the liver : A phase III multicentre study Acta Radiologica
doi_str_mv 10.1080/02841859709172395
facet_avail Online
finc_class_facet Technik
Physik
Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA4MC8wMjg0MTg1OTcwOTE3MjM5NQ
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA4MC8wMjg0MTg1OTcwOTE3MjM5NQ
institution DE-15
DE-Pl11
DE-Rs1
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-D161
DE-Gla1
DE-Zi4
imprint SAGE Publications, 1997
imprint_str_mv SAGE Publications, 1997
issn 0284-1851
1600-0455
issn_str_mv 0284-1851
1600-0455
language English
mega_collection SAGE Publications (CrossRef)
match_str wang1997diagnosticefficacyofmndpdpinmrimagingoftheliveraphaseiiimulticentrestudyaphaseiiimulticentrestudy
publishDateSort 1997
publisher SAGE Publications
recordtype ai
record_format ai
series Acta Radiologica
source_id 49
title_sub A phase III multicentre study
title Diagnostic efficacy of MnDPDP in MR imaging of the liver : A phase III multicentre study
title_unstemmed Diagnostic efficacy of MnDPDP in MR imaging of the liver : A phase III multicentre study
title_full Diagnostic efficacy of MnDPDP in MR imaging of the liver : A phase III multicentre study
title_fullStr Diagnostic efficacy of MnDPDP in MR imaging of the liver : A phase III multicentre study
title_full_unstemmed Diagnostic efficacy of MnDPDP in MR imaging of the liver : A phase III multicentre study
title_short Diagnostic efficacy of MnDPDP in MR imaging of the liver : A phase III multicentre study
title_sort diagnostic efficacy of mndpdp in mr imaging of the liver : a phase iii multicentre study
topic Radiology, Nuclear Medicine and imaging
General Medicine
Radiological and Ultrasound Technology
url http://dx.doi.org/10.1080/02841859709172395
publishDate 1997
physical 643-649
description <jats:p> Purpose: To assess the diagnostic efficacy, safety and tolerability of mangafodipir trisodium (MnDPDP, Teslascan) in MR imaging of the liver. </jats:p><jats:p> Material and Methods: Eighty-two patients from 4 centres underwent MR imaging with pre-contrast sequences including T1-weighted SE and GRE, and T2-weighted turbo SE sequences. MnDPDP at a dose of 5 μmol/kg b.w. was administered by slow i.v. infusion, and 20–60 min after infusion the T1-weighted SE and GRE sequences were repeated. Diagnostic efficacy was evaluated by counting the number of lesions and by evaluating whether more information for lesion characterisation was available in post-contrast images. Safety and tolerability were assessed by recording adverse events and infusion-related discomfort. </jats:p><jats:p> Results: Significantly more lesions were found in MnDPDP-enhanced T1-weighted SE and GRE images than in unenhanced images of the same sequences. More lesions were also found in these images compared with T2-weighted images at a level of marginal significance. More information was obtained from MnDPDP-enhanced images in 40 cases. Mild to moderate adverse events were experienced by 17% of the patients. </jats:p><jats:p> Conclusion: MnDPDP-enhanced images can improve lesion detection in the liver and are helpful for lesion characterisation. To obtain optimal diagnostic information of liver lesions T2-weighted images are also valuable. MnDPDP is a safe contrast agent for MR imaging of liver lesions. </jats:p>
container_issue 5
container_start_page 643
container_title Acta Radiologica
container_volume 38
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792337308188409871
geogr_code not assigned
last_indexed 2024-03-01T15:13:43.296Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Diagnostic+efficacy+of+MnDPDP+in+MR+imaging+of+the+liver+%3A+A+phase+III+multicentre+study&rft.date=1997-09-01&genre=article&issn=1600-0455&volume=38&issue=5&spage=643&epage=649&pages=643-649&jtitle=Acta+Radiologica&atitle=Diagnostic+efficacy+of+MnDPDP+in+MR+imaging+of+the+liver+%3A+A+phase+III+multicentre+study&aulast=Westman&aufirst=L.&rft_id=info%3Adoi%2F10.1080%2F02841859709172395&rft.language%5B0%5D=eng
SOLR
_version_ 1792337308188409871
author Wang, C., Ahlström, H., Ekholm, S., Fagertun, H., Hellström, M., Hemmingsson, A., Holtås, S., Isberg, B., Jonnson, E., Lönnemark-Magnusson, M., McGill, S., Wallengren, N.-O., Westman, L.
author_facet Wang, C., Ahlström, H., Ekholm, S., Fagertun, H., Hellström, M., Hemmingsson, A., Holtås, S., Isberg, B., Jonnson, E., Lönnemark-Magnusson, M., McGill, S., Wallengren, N.-O., Westman, L., Wang, C., Ahlström, H., Ekholm, S., Fagertun, H., Hellström, M., Hemmingsson, A., Holtås, S., Isberg, B., Jonnson, E., Lönnemark-Magnusson, M., McGill, S., Wallengren, N.-O., Westman, L.
author_sort wang, c.
container_issue 5
container_start_page 643
container_title Acta Radiologica
container_volume 38
description <jats:p> Purpose: To assess the diagnostic efficacy, safety and tolerability of mangafodipir trisodium (MnDPDP, Teslascan) in MR imaging of the liver. </jats:p><jats:p> Material and Methods: Eighty-two patients from 4 centres underwent MR imaging with pre-contrast sequences including T1-weighted SE and GRE, and T2-weighted turbo SE sequences. MnDPDP at a dose of 5 μmol/kg b.w. was administered by slow i.v. infusion, and 20–60 min after infusion the T1-weighted SE and GRE sequences were repeated. Diagnostic efficacy was evaluated by counting the number of lesions and by evaluating whether more information for lesion characterisation was available in post-contrast images. Safety and tolerability were assessed by recording adverse events and infusion-related discomfort. </jats:p><jats:p> Results: Significantly more lesions were found in MnDPDP-enhanced T1-weighted SE and GRE images than in unenhanced images of the same sequences. More lesions were also found in these images compared with T2-weighted images at a level of marginal significance. More information was obtained from MnDPDP-enhanced images in 40 cases. Mild to moderate adverse events were experienced by 17% of the patients. </jats:p><jats:p> Conclusion: MnDPDP-enhanced images can improve lesion detection in the liver and are helpful for lesion characterisation. To obtain optimal diagnostic information of liver lesions T2-weighted images are also valuable. MnDPDP is a safe contrast agent for MR imaging of liver lesions. </jats:p>
doi_str_mv 10.1080/02841859709172395
facet_avail Online
finc_class_facet Technik, Physik, Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA4MC8wMjg0MTg1OTcwOTE3MjM5NQ
imprint SAGE Publications, 1997
imprint_str_mv SAGE Publications, 1997
institution DE-15, DE-Pl11, DE-Rs1, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Gla1, DE-Zi4
issn 0284-1851, 1600-0455
issn_str_mv 0284-1851, 1600-0455
language English
last_indexed 2024-03-01T15:13:43.296Z
match_str wang1997diagnosticefficacyofmndpdpinmrimagingoftheliveraphaseiiimulticentrestudyaphaseiiimulticentrestudy
mega_collection SAGE Publications (CrossRef)
physical 643-649
publishDate 1997
publishDateSort 1997
publisher SAGE Publications
record_format ai
recordtype ai
series Acta Radiologica
source_id 49
spelling Wang, C. Ahlström, H. Ekholm, S. Fagertun, H. Hellström, M. Hemmingsson, A. Holtås, S. Isberg, B. Jonnson, E. Lönnemark-Magnusson, M. McGill, S. Wallengren, N.-O. Westman, L. 0284-1851 1600-0455 SAGE Publications Radiology, Nuclear Medicine and imaging General Medicine Radiological and Ultrasound Technology http://dx.doi.org/10.1080/02841859709172395 <jats:p> Purpose: To assess the diagnostic efficacy, safety and tolerability of mangafodipir trisodium (MnDPDP, Teslascan) in MR imaging of the liver. </jats:p><jats:p> Material and Methods: Eighty-two patients from 4 centres underwent MR imaging with pre-contrast sequences including T1-weighted SE and GRE, and T2-weighted turbo SE sequences. MnDPDP at a dose of 5 μmol/kg b.w. was administered by slow i.v. infusion, and 20–60 min after infusion the T1-weighted SE and GRE sequences were repeated. Diagnostic efficacy was evaluated by counting the number of lesions and by evaluating whether more information for lesion characterisation was available in post-contrast images. Safety and tolerability were assessed by recording adverse events and infusion-related discomfort. </jats:p><jats:p> Results: Significantly more lesions were found in MnDPDP-enhanced T1-weighted SE and GRE images than in unenhanced images of the same sequences. More lesions were also found in these images compared with T2-weighted images at a level of marginal significance. More information was obtained from MnDPDP-enhanced images in 40 cases. Mild to moderate adverse events were experienced by 17% of the patients. </jats:p><jats:p> Conclusion: MnDPDP-enhanced images can improve lesion detection in the liver and are helpful for lesion characterisation. To obtain optimal diagnostic information of liver lesions T2-weighted images are also valuable. MnDPDP is a safe contrast agent for MR imaging of liver lesions. </jats:p> A phase III multicentre study Diagnostic efficacy of MnDPDP in MR imaging of the liver : A phase III multicentre study Acta Radiologica
spellingShingle Wang, C., Ahlström, H., Ekholm, S., Fagertun, H., Hellström, M., Hemmingsson, A., Holtås, S., Isberg, B., Jonnson, E., Lönnemark-Magnusson, M., McGill, S., Wallengren, N.-O., Westman, L., Acta Radiologica, Diagnostic efficacy of MnDPDP in MR imaging of the liver : A phase III multicentre study, Radiology, Nuclear Medicine and imaging, General Medicine, Radiological and Ultrasound Technology
title Diagnostic efficacy of MnDPDP in MR imaging of the liver : A phase III multicentre study
title_full Diagnostic efficacy of MnDPDP in MR imaging of the liver : A phase III multicentre study
title_fullStr Diagnostic efficacy of MnDPDP in MR imaging of the liver : A phase III multicentre study
title_full_unstemmed Diagnostic efficacy of MnDPDP in MR imaging of the liver : A phase III multicentre study
title_short Diagnostic efficacy of MnDPDP in MR imaging of the liver : A phase III multicentre study
title_sort diagnostic efficacy of mndpdp in mr imaging of the liver : a phase iii multicentre study
title_sub A phase III multicentre study
title_unstemmed Diagnostic efficacy of MnDPDP in MR imaging of the liver : A phase III multicentre study
topic Radiology, Nuclear Medicine and imaging, General Medicine, Radiological and Ultrasound Technology
url http://dx.doi.org/10.1080/02841859709172395